companydata.dkcompanydata.dk

Hanne Damgaard Jensen

PersonUnit number: 4000590734
Roskilde
1
Ownership
5
Board positions
4
Director positions
2
Other roles
55
People in network

People in network(55)

People who held roles at the same companies, or who co-own the same companies

Ulrik Spork
ROS Therapeutics ApS, ROS Therapeutics Holding ApS
Lars Aaen
AZANTA DANMARK A/S, AZANTA A/S
Jens Munch-Hansen
AZANTA DANMARK A/S, AZANTA A/S

Ownership(1)

HDJ & LEJ Invest ApS
CVR: 39497441
EJERREGISTER
100%
Ownership
Active

Board positions(2)

ROS Therapeutics ApS
CVR: 39507501
BESTYRELSESMEDLEM
Active
Since 12. okt. 2018
MLMC Therapeutics ApS
CVR: 41277688
BESTYRELSESMEDLEM
Active
Since 3. apr. 2020

Director positions(3)

ROS Therapeutics ApS
CVR: 39507501
ADM. DIR.
Active
Since 23. apr. 2018
ROS Therapeutics Holding ApS
CVR: 39507056
DIREKTØR
Active
Since 23. apr. 2018
HDJ & LEJ Invest ApS
CVR: 39497441
DIREKTØR
Active
Since 17. apr. 2018

Other roles(2)

REGUNIC v/Hanne Damgaard Jensen
CVR: 30384946
INTERESSENTER
Active
Since 1. apr. 2007
HDJ & LEJ Invest ApS
CVR: 39497441
STIFTERE
Active
Since 17. apr. 2018

Indirect ownership(3)

Companies owned indirectly through ownership chains.

66,66-89,99%
Effective ownership
Depth: 1
Ownership path:
HDJ & LEJ Invest ApS(100%)
→ROS Therapeutics Holding ApS(66,66-89,99%)
33,33-49,99%
Effective ownership
Depth: 2
Ownership path:
HDJ & LEJ Invest ApS(100%)
→ROS Therapeutics Holding ApS(66,66-89,99%)
→ROS Therapeutics ApS(50-66,65%)
5-9,99%
Effective ownership
Depth: 1
Ownership path:
HDJ & LEJ Invest ApS(100%)
→MLMC Therapeutics ApS(5-9,99%)

Former board positions(3)

AZANTA DANMARK A/S
CVR: 25260279
FORMAND
Ended
Since 30. apr. 2015
Until 14. mar. 2017
ROS Therapeutics Holding ApS
CVR: 39507056
FORMAND
Ended
Since 23. apr. 2018
Until 24. jun. 2019
AimVion A/S
CVR: 37120618
FORMAND
Dissolved
Ended
Since 30. okt. 2019
Until 7. apr. 2022

Former director positions(1)

AZANTA A/S
CVR: 28108915
ADM. DIR.
Ended
Since 21. apr. 2015
Until 28. feb. 2017